Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2012, Article ID 142530, 5 pages
http://dx.doi.org/10.1155/2012/142530
Research Article

Marrow Stromal Cell Infusion Rescues Hematopoiesis in Lethally Irradiated Mice despite Rapid Clearance after Infusion

1Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
2Clinical Research Division, Fred Hutchinson Cancer Research Centre, Seattle, WA 98109, USA

Received 1 September 2011; Accepted 16 November 2011

Academic Editor: Helen Dimitriou

Copyright © 2012 Xiaodong Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. V. Karkanitsa, “Radiation damage to hematopoiesis: what do we know better?” Stem Cells, vol. 15, pp. 71–73, 1997. View at Google Scholar · View at Scopus
  2. F. Hérodin, N. Grenier, and M. Drouet, “Revisiting therapeutic strategies in radiation casualties,” Experimental Hematology, vol. 35, no. 4, supplement 1, pp. 28–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. E. Moulder, “Post-irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: a review,” International Journal of Radiation Biology, vol. 80, no. 1, pp. 3–10, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Hérodin and M. Drouet, “Cytokine-based treatment of accidentally irradiated victims and new approaches,” Experimental Hematology, vol. 33, no. 10, pp. 1071–1080, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. P. Gale and A. Butturini, “The role of hematopoietic growth factors in nuclear and radiation accidents,” Experimental Hematology, vol. 18, no. 8, pp. 958–964, 1990. View at Google Scholar · View at Scopus
  6. R. P. Gale and A. Butturini, “Use of hematopoietic growth factors in radiation accidents,” International Journal of Radiation Oncology Biology Physics, vol. 19, no. 5, pp. 1291–1295, 1990. View at Google Scholar · View at Scopus
  7. T. M. Fliedner, N. J. Chao, J. L. Bader et al., “Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop,” Stem Cells, vol. 27, no. 5, pp. 1205–1211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Le Blanc, I. Rasmusson, B. Sundberg et al., “Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells,” The Lancet, vol. 363, no. 9419, pp. 1439–1441, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Parekkadan and J. M. Milwid, “Mesenchymal stem cells as therapeutics,” 2010, http://www.annualreviews.org/doi/full/10.1146/annurev-bioeng-070909-105309?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&. View at Google Scholar
  10. L. Vija, D. Farge, J. F. Gautier et al., “Mesenchymal stem cells: stem cell therapy perspectives for type 1 diabetes,” Diabetes and Metabolism, vol. 35, no. 2, pp. 85–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. L. C. Amado, A. P. Saliaris, K. H. Schuleri et al., “Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 32, pp. 11474–11479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Lange, B. Brunswig-Spickenheier, H. Cappallo-Obermann et al., “Radiation rescue: mesenchymal stromal cells protect from lethal irradiation,” PLoS ONE, vol. 6, no. 1, Article ID e14486, 2011. View at Publisher · View at Google Scholar
  13. K. X. Hu, Q. Y. Sun, M. Guo, and H. S. Ai, “The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury,” British Journal of Radiology, vol. 83, no. 985, pp. 52–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. B. A. Roecklein and B. Torok-Storb, “Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes,” Blood, vol. 85, no. 4, pp. 997–1005, 1995. View at Google Scholar · View at Scopus
  15. A. Sorrentino, M. Ferracin, G. Castelli et al., “Isolation and characterization of CD146+ multipotent mesenchymal stromal cells,” Experimental Hematology, vol. 36, no. 8, pp. 1035–1046, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Lin, J. Molter, Z. Lee, and S. L. Gerson, “Bioluminescence imaging of hematopoietic stem cell repopulation in murine models,” Methods in Molecular Biology, vol. 430, pp. 295–306, 2008. View at Google Scholar · View at Scopus
  17. G. Yang, A. Abate, A. G. George, Y. H. Weng, and P. A. Dennery, “Maturational differences in lung NF-κB activation and their role in tolerance to hyperoxia,” Journal of Clinical Investigation, vol. 114, no. 5, pp. 669–678, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. C. M. Assis, J. L. Carvalho, B. A. Jacoby et al., “Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart,” Cell Transplantation, vol. 19, no. 2, pp. 219–230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. I. M. Barbash, P. Chouraqui, J. Baron et al., “Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution,” Circulation, vol. 108, no. 7, pp. 863–868, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Gao, J. E. Dennis, R. F. Muzic, M. Lundberg, and A. I. Caplan, “The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion,” Cells Tissues Organs, vol. 169, no. 1, pp. 12–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. D. L. Kraitchman, A. W. Heldman, E. Atalar et al., “In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction,” Circulation, vol. 107, no. 18, pp. 2290–2293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Lange, F. Tögel, H. Ittrich et al., “Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats,” Kidney International, vol. 68, no. 4, pp. 1613–1617, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. J. Min, Y. Ahn, S. Moon et al., “In vivo bioluminescence imaging of cord blood derived mesenchymal stem cell transplantation into rat myocardium,” Annals of Nuclear Medicine, vol. 20, no. 3, pp. 165–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Tögel, Y. Yang, P. Zhang, Z. Hu, and C. Westenfelder, “Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury,” American Journal of Physiology, vol. 295, no. 1, pp. F315–F321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Weir, M. C. Morel-Kopp, A. Gill et al., “Mesenchymal stem cells: isolation, characterisation and in vivo fluorescent dye tracking,” Heart Lung and Circulation, vol. 17, no. 5, pp. 395–403, 2008. View at Publisher · View at Google Scholar · View at Scopus